Wuhong Chen
State Key Laboratory Of Drug Research
Shanghai, 201203, China
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Natural product-based Ebola virus entry inhibitors targeting the viral glycoprotein: A combined computational and experimental study.
Journal: Antiviral research
Published: March 25, 2026
Structural optimization of phthalazine derivatives for anti-HBV activities to improve oral bioavailability.
Journal: Bioorganic & medicinal chemistry
Published: April 10, 2025
Discovery of novel Ebola entry inhibitors with 1,2,3,4-tetrahydroisoquinoline-3-carboxamide based on (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold.
Journal: Bioorganic & medicinal chemistry letters
Published: November 20, 2024
A prodrug of the capsid assembly modulator improved druggability and lowing HBsAg and HBeAg for the treatment of chronic hepatitis B.
Journal: European journal of medicinal chemistry
Published: March 15, 2023
A novel phthalazinone derivative as a capsid assembly modulator inhibits hepatitis B virus expression.
Journal: Antiviral research
Published: February 03, 2023
Discovery of highly potent SARS-CoV-2 Mpro inhibitors based on benzoisothiazolone scaffold.
Journal: Bioorganic & medicinal chemistry letters
Published: November 15, 2021
Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 22, 2020
Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors.
Journal: European journal of medicinal chemistry
Published: October 12, 2017
Discovery of a low-systemic-exposure DGAT-1 inhibitor with a picolinoylpyrrolidine-2-carboxylic acid moiety.
Journal: Bioorganic & medicinal chemistry
Published: May 20, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026